α5β1 integrin expression is significantly upregulated in cisplatin-resistant esophageal SCC cell lines Eca109 and TE-1 and contributes to cisplatin resistance by activating the FAK/PI3K/Akt/BRAD1 signaling pathway [47]. Here, AKT1 is linked to esophageal squamous cell carcinoma.